SAN FRANCISCO & NEW DELHI, India--(BUSINESS WIRE)--The Institute for OneWorld Health, a US-based non-profit pharmaceutical company, today announced that its first approved drug product, Paromomycin IM Injection, was designated by the World Health Organization (WHO) for inclusion on its Model List for Essential Medicines.
